20 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26288216	579	Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3.	Amgen
23084278	21	Structure-activity relationship exploration of Kv1.3 blockers based on diphenoxylate.	Monash University (Parkville Campus)
18289849	8	Synthesis and biological evaluation of chalcones as inhibitors of the voltage-gated potassium channel Kv1.3.	The Walter and Eliza Hall Institute of Medical Research
11356099	20	Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.	Abbott Laboratories
20974533	99	Substituted N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 ion channel blockers. Part 2.	Glaxosmithkline
20971642	59	N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1.	Glaxosmithkline
19888755	43	Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia.	Wyeth Research
19056148	27	4-Phenoxybutoxy-substituted heterocycles--a structure-activity relationship study of blockers of the lymphocyte potassium channel Kv1.3.	University of California
	1	The SAR of UK-78,282: A novel blocker of human T cell Kv1.3 potassium channels	TBA
19282171	29	Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants.	4Sc
19042133	4	Gamma-pyrone natural products--a privileged compound class provided by nature.	Institute of Molecular Physiology
15603971	63	Potent Kv1.3 inhibitors from correolide-modification of the C18 position.	Merck Research Laboratories
15084131	27	Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity.	Institute of Medical Research Biotechnology Centre
12643934	109	Benzamide derivatives as blockers of Kv1.3 ion channel.	Merck Research Laboratories
12570371	33	Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5.	Aventis Pharma Deutschland
10612582	13	Blockers of human T cell Kv1.3 potassium channels using de novo ligand design and solid-phase parallel combinatorial chemistry.	University of California
7540207	56	Novel inhibitors of potassium ion channels on human T lymphocytes.	Sanofi Winthrop
28802123	89	Clathrodin, hymenidin and oroidin, and their synthetic analogues as inhibitors of the voltage-gated potassium channels.	University of Ljubljana